143 Jaksot

  1. Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review

    Julkaistiin: 2.2.2023
  2. Basics of prostate cancer pathology

    Julkaistiin: 26.1.2023
  3. Oligometastaic breast cancer

    Julkaistiin: 19.1.2023
  4. Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias

    Julkaistiin: 12.1.2023
  5. Summary/Review - Reporting Guidelines - CHEERS

    Julkaistiin: 6.12.2022
  6. Role of immunotherapy in head and neck cancer

    Julkaistiin: 1.12.2022
  7. AYAs with cancer: the right to be forgotten

    Julkaistiin: 24.11.2022
  8. Summary/Review - Reporting Guidelines - SQUIRE

    Julkaistiin: 17.11.2022
  9. Male breast cancer

    Julkaistiin: 10.11.2022
  10. Summary/Review - Reporting Guidelines - SRQR

    Julkaistiin: 3.11.2022
  11. Summary/Review - Reporting Guidelines - AGREE

    Julkaistiin: 27.10.2022
  12. Breast Cancer: Frequently Asked Questions and Answers

    Julkaistiin: 20.10.2022
  13. The role of Medical Physicist in Oncology

    Julkaistiin: 13.10.2022
  14. How to approach to breast cancer patient who had not received neoadjuvant chemo and staged T2NO postoperatively?

    Julkaistiin: 6.10.2022
  15. Parp inhibitors in ovarian cancer

    Julkaistiin: 29.9.2022
  16. Primary endocrine resistant in recurrent locoregional only Breast cancer (role of endocrine therapy)

    Julkaistiin: 22.9.2022
  17. Should Prostate Cancer Patients With History of Cardiovascular Events Be Preferentially Treated With Luteinizing Hormone-Releasing Hormone Antagonists?

    Julkaistiin: 15.9.2022
  18. The use of Lutetium PSMA as treatment in mCRPC – in what sequence and how to best select patients

    Julkaistiin: 8.9.2022
  19. Use of Medical Cannabis in Oncology. Knowledges and attitudes among oncologist and patient.

    Julkaistiin: 1.9.2022
  20. Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?

    Julkaistiin: 27.7.2022

4 / 8

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net

Visit the podcast's native language site